No Data
chinahealthwise (00348.HK): Liang Yixi appointed as the authorized representative.
Chinahealthwise (00348.HK) announced that Xie Zhiqiang resigned as an executive director to devote more time to his personal affairs, in accordance with Rule 3.05 of the Securities Listing Rules of the Hong Kong Stock Exchange, effective September 30, 2024. Executive director Liang Yixi was appointed as the authorized representative effective September 30, 2024.
CHINAHEALTHWISE: Interim Report 2024
Chinahealthwise (00348.HK) narrowed its half-year loss to 28.66 million yuan.
Chinahealthwise (00348.HK) announced its interim performance for the six months ended in June, with revenue of HKD 60.93 million, a year-on-year decrease of 24.6%. The loss narrowed from HKD 31.86 million in the same period last year to HKD 28.66 million, with a loss per share of 3.72 cents. No interim dividend will be distributed.
chinahealthwise (00348) announced its interim performance, with a net loss of 28.663 million Hong Kong dollars, a year-on-year narrowing of 10.04%.
chinahealthwise (00348) announced its mid-term performance in 2024, with revenue of 60.932 million Hong Kong dollars, a year-on-year decrease...
CHINAHEALTHWISE: UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
CHINAHEALTHWISE: SUPPLEMENTAL ANNOUNCEMENT ON THE ANNUAL REPORTFOR THE YEAR ENDED 31 DECEMBER 2023
No Data
No Data